Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Repare Therapeutics Inc (NASDAQ: RPTX) closed at $0.93 up 3.13% from its previous closing price of $0.90. In other words, the price has increased by $3.13 from its previous closing price. On the day, 0.72 million shares were traded. RPTX stock price reached its highest trading level at $0.93 during the session, while it also had its lowest trading level at $0.89.
Ratios:
For a deeper understanding of Repare Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.77 and its Current Ratio is at 6.77. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on June 09, 2023, Upgraded its rating to Buy and sets its target price to $16 from $11 previously.
On February 03, 2023, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $28 to $15.
On January 06, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $28.CapitalOne initiated its Overweight rating on January 06, 2023, with a $28 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 12 ’25 when Koehler Maria sold 3,596 shares for $1.14 per share. The transaction valued at 4,099 led to the insider holds 227,813 shares of the business.
Zinda Michael sold 5,611 shares of RPTX for $6,397 on Mar 12 ’25. The EVP, CHIEF SCIENTIFIC OFFICER now owns 80,297 shares after completing the transaction at $1.14 per share. On Mar 12 ’25, another insider, Forte Steve, who serves as the EVP, CHIEF FINANCIAL OFFICER of the company, sold 6,884 shares for $1.14 each. As a result, the insider received 7,848 and left with 54,786 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RPTX now has a Market Capitalization of 39458432 and an Enterprise Value of -111399560. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.74 while its Price-to-Book (P/B) ratio in mrq is 0.26. Its current Enterprise Value per Revenue stands at -2.083 whereas that against EBITDA is 1.235.
Stock Price History:
The Beta on a monthly basis for RPTX is 0.91, which has changed by -0.7221557 over the last 52 weeks, in comparison to a change of 0.07019031 over the same period for the S&P500. Over the past 52 weeks, RPTX has reached a high of $4.29, while it has fallen to a 52-week low of $0.89. The 50-Day Moving Average of the stock is -18.15%, while the 200-Day Moving Average is calculated to be -62.11%.
Shares Statistics:
For the past three months, RPTX has traded an average of 241.82K shares per day and 322170 over the past ten days. A total of 42.51M shares are outstanding, with a floating share count of 30.52M. Insiders hold about 28.21% of the company’s shares, while institutions hold 43.02% stake in the company. Shares short for RPTX as of 1743379200 were 795854 with a Short Ratio of 3.29, compared to 1740700800 on 1059894. Therefore, it implies a Short% of Shares Outstanding of 795854 and a Short% of Float of 3.1.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
